Canada Research Chair in the Molecular Imaging of Diabetes
Globally, type 2 diabetes (T2D) causes one out of five or six deaths in middle-aged women and men, respectively. Clinical management focuses mainly on blood glucose level control. However, fat metabolism disorders involving white and brown adipose tissues (WAT and BAT) and the heart occur earlier, playing a crucial role in T2D and its complications.
Using innovative molecular imaging methods, the Canada Research Chair in the Molecular Imaging of Diabetes will investigate whether the sex-specific mechanisms explaining enhanced cardiac fat channeling could constitute a target for prevention of heart failure, and will define the role of BAT as a target for the prevention of T2D.
Main Objective of the Research Program
Validate the risk markers and early targets for the prevention of type 2 diabetes.
Chairholder
André Carpentier
Profile
André Carpentier is a professor in the Department of Medicine of the Faculty of Medicine and Health Sciences.
He is also the scientific director of the Centre de recherche du CHUS (CRCHUS), and endocrinologist at the CIUSSS de l’Estrie - CHUS.
Fields of research and expertise
Diabetes, Fatty acid metabolism, Molecular Imaging, Positron Emission Tomography, Stable Isotopic Tracers, Adipose Tissues, Type 2 Diabetes, Thermogenesis, Obesity, Adipose Tissue Metabolic Function
Research Relevance
Development of new diagnostic and therapeutic tools for type 2 diabetes.
Funding
- Canada Research Chairs Program
- Canadian Institutes of Health Research
Additional Information
- Tier 1 Chair - 2018-01-10